Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Kountouras, J., Zavos C., Gavalas E., Deretzi G., Tsona A., Katsinelos P., et al. (2012).  A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.. Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
Kountouras, J., Zavos C., Polyzos S. A., Michael S., Tsiaousi E., Vardaka E., et al. (2013).  Relationship between Helicobacter pylori infection and autoimmune disorders.. Clin Chem Lab Med. 51(5), e73-4.
Gavalas, E., Kountouras J., Boziki M., Zavos C., Polyzos S. A., Vlachaki E., et al. (2015).  Relationship between Helicobacter pylori infection and multiple sclerosis.. Ann Gastroenterol. 28(3), 353-356.
Makras, P., Yavropoulou M. P., Polyzos S. A., Papapoulos S. E., Georgakopoulou D., Papatheodorou A., et al. (2023).  The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.. Osteoporos Int.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Vardaka E., et al. (2019).  The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies.. Scand J Gastroenterol. 1-2.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Response to letter to the editor of Carcinogenesis by Li et al., 2020.. Carcinogenesis. 41(4), 539-540.
Orfanidou, M., Ntenti C., Evripidou K., Mataftsi A., Goulas A., & Polyzos S. A. (2023).  Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.. J Pers Med. 13(7), 
Polyzos, S. A., Kechagias S., & Tsochatzis E. A. (2021).  Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.. Aliment Pharmacol Ther.
Doulberis, M., Kotronis G., Thomann R., Polyzos S. A., Boziki M., Gialamprinou D., et al. (2018).  Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter. 23(1), 
Doulberis, M., Papaefthymiou A., Polyzos S. A., Katsinelos P., Grigoriadis N., Srivastava D. S., et al. (2020).  Rodent models of obesity.. Minerva Endocrinol. 45(3), 243-263.
Polyzos, S. A., Kountouras J., Zavos C., & Tsiaousi E. (2010).  The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.. Diabetes Obes Metab. 12(5), 365-83.
Papaefthymiou, A., Christodoulidis G., Koffas A., Doulberis M., Polyzos S. A., Manolakis A., et al. (2021).  Role of autophagy in gastric carcinogenesis.. World J Gastrointest Oncol. 13(10), 1244-1262.
Anastasilakis, A. D., Polyzos S. A., Delaroudis S., Bisbinas I., Sakellariou G. T., Gkiomisi A., et al. (2012).  The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.. Clin Endocrinol (Oxf). 77(6), 816-22.
Tsiampali, C., Papaioannidou P., Goulas A., & Polyzos S. A. (2023).  The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease.. Expert Rev Clin Pharmacol. 1-10.
Polyzos, S. A., & Targher G. (2024).  Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.. Curr Obes Rep.
Vachliotis, I. D., & Polyzos S. A. (2023).  The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.. Curr Obes Rep.
Anastasilakis, A. D., Polyzos S. A., & Toulis K. A. (2011).  Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.. Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
S
Polyzos, S. A., Vachliotis I. D., & Mantzoros C. S. (2023).  Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.. Metabolism. 147, 155676.
Polyzos, S. A., & Mantzoros C. S. (2023).  Sarcopenia: still in relative definition-penia and severe treatment-penia.. Metabolism. 155717.
Polyzos, S. A., & Margioris A. N. (2018).  Sarcopenic obesity.. Hormones (Athens). 17(3), 321-331.
Avramidis, A., Polyzos S. A., Moralidis E., Arsos G., Efstathiadou Z., Karakatsanis K., et al. (2008).  Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.. J Bone Miner Metab. 26(6), 635-41.
Polyzos, S. A., Kountouras J., Goulas A., & Duntas L. (2020).  Selenium and selenoprotein P in nonalcoholic fatty liver disease.. Hormones (Athens). 19(1), 61-72.
Polyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., et al. (2019).  Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.. Exp Clin Endocrinol Diabetes.
Polyzos, S. A., & Katsiki N. (2022).  Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer.. Hormones (Athens).
Pazaitou-Panayiotou, K., Panagiotou G., Polyzos S. A., & Mantzoros C. S. (2016).  SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.. Endocr Pract. 22(1), 68-75.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές